搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Seeking Alpha
36 分钟
Garrett Motion: Engineering Value Beyond The Engine
Industry Transition Risk: The automotive industry is rapidly shifting toward electrification. While Garrett is investing in ...
14 小时
BioAge stock craters 70% on obesity drug study halt (update)
BioAge (BIOA) stock cratered 70% Friday evening after the company said it was discontinuing a Phase 2 study for its ...
2 小时
Ethereum: Still Bullish At $4K, But These Altcoins Might Outperform In 2025
Ethereum has been lagging behind other cryptocurrencies in price appreciation and some functionality. Learn more about ...
2 小时
Tri Pointe Homes: Returns Fading, Now At Fair Value
Despite recent tailwinds and growth, my view is high inflation has overstated Tri Pointe Homes' revenues and earnings. Read ...
2 小时
Nuvalent: Steps Toward That Favorable Entry Point
Nuvalent, Inc. has promising drugs, zidesamtinib and NVL-655, targeting NSCLC with encouraging data. Read why NUVL stock is a ...
Seeking Alpha
2 小时
TD Bank: Massive Overreaction (Rating Upgrade)
Toronto-Dominion Bank released its earnings Thursday. The release was mixed, beating on revenue but missing on adjusted ...
Seeking Alpha
2 小时
Now Is Still A Great Time To Consider MTBA
The Fed hiked rates by 525 basis points over a nearly two-year period, providing attractive yields across all fixed income ...
3 小时
Total Return Breakouts: Palantir, Quantum Computing And Value Investing
Quantum computing and algorithmic trading models can enhance portfolio performance across various sectors. Read why strong ...
4 小时
PepsiCo: Appeal Improves Despite Concerns
Despite PepsiCo's solid financials and modest leverage, weak volume trends and political changes raise concerns. Read why PEP ...
4 小时
Enterprise Products Partners: Unusual Insider Activities Signal Strong Buy Opportunity
Enterprise Products Partners is still discounted, judging by its PEGY ratio and comparison against close peers. Read why I've ...
4 小时
Ameren: Getting Difficult To Justify The Valuation
Ameren's operating income and net income declined due to higher operating expenses and regulatory changes in Illinois. Read ...
3 小时
Deramiocel's Promise Brightens Capricor's Outlook, With Strings Attached
Capricor Therapeutics is advancing deramiocel for DMD-related cardiomyopathy, with FDA approval potential by 2025. Read why ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈